 | Up a level |
Schmid, P; Mordasini, A; Luginbühl, M; Regli, B; Kohler, H P; Zimmermann, H; Inderbitzin, D; Hirt, A; Lämmle, B; Alberio, L (2011). Low-dose recombinant factor VIIa for massive bleeding: A single centre observational cohort study with 73 patients. Swiss medical weekly, 141, w13213. Muttenz: EMH Schweizerischer Ärzteverlag 10.4414/smw.2011.13213
Luginbühl, R; Barizzi, G; Sulzer, I; Lämmle, B; Alberio, L (2010). Screening for lupus anticoagulant: improving the performance of the lupus-sensitive PTT-LA. International journal of laboratory hematology, 33(2), pp. 168-175. Oxford: Blackwell Scientific Publications 10.1111/j.1751-553X.2010.01262.x
Schneiter, S; Colucci, G; Sulzer, I; Barizzi, G; Lämmle, B; Alberio, L (2009). Variability of anti-PF4/heparin antibody results obtained by the rapid testing system ID-H/PF4-PaGIA. Journal of thrombosis and haemostasis, 7(10), pp. 1649-55. Oxford: Wiley-Blackwell 10.1111/j.1538-7836.2009.03507.x
Colucci, G; Lämmle, B; Alberio, L (2009). Variability of anti-PF4/heparin antibody results obtained by the rapid testing system ID-H/PF4-PaGIA: reply to a rebuttal. Journal of thrombosis and haemostasis, 7(10), pp. 1755-1756. Oxford: Wiley-Blackwell 10.1111/j.1538-7836.2009.03517.x
Bergmann, I P; Kremer Hovinga, J A; Lämmle, B; Peter, H J; Schiemann, U (2008). Acute pancreatitis and thrombotic thrombocytopenic purpura. European journal of medical research, 13(10), pp. 481-2. München: I. Holzapfel
Tripodi, A; Peyvandi, F; Chantarangkul, V; Palla, R; Afrasiabi, A; Canciani, M T; Chung, D W; Ferrari, S; Fujimura, Y; Karimi, M; Kokame, K; Kremer Hovinga, J A; Lämmle, B; de Meyer, S F; Plaimauer, B; Vanhoorelbeke, K; Varadi, K; Mannucci, P M (2008). Second international collaborative study evaluating performance characteristics of methods measuring the von Willebrand factor cleaving protease (ADAMTS-13). Journal of thrombosis and haemostasis, 6(9), pp. 1534-41. Oxford: Blackwell 10.1111/j.1538-7836.2008.03099.x
Alberio, L; Lämmle, B (2008). Stability of coagulation assays performed in plasma from citrated whole blood transportet at ambient temperatur: only a part of the story. Reply to E. J. Favoloro. Thrombosis and haemostasis, 99(8), p. 1123. Stuttgart: Schattauer 10.1160/TH08-05-0279
Kremer Hovinga, J A; Zeerleder, S; Kessler, P; Romani de Wit, T; van Mourik, J A; Hack, C E; ten Cate, H; Reitsma, P H; Wuillemin, W A; Lämmle, B (2007). ADAMTS-13, von Willebrand factor and related parameters in severe sepsis and septic shock. Journal of thrombosis and haemostasis, 5(11), pp. 2284-90. Oxford: Blackwell 10.1111/j.1538-7836.2007.02743.x
Meyer, S C; Sulzer, I; Lämmle, B; Kremer Hovinga, J A (2007). Hyperbilirubinemia interferes with ADAMTS-13 activity measurement by FRETS-VWF73 assay: diagnostic relevance in patients suffering from acute thrombotic microangiopathies. Journal of thrombosis and haemostasis, 5(4), pp. 866-7. Oxford: Blackwell 10.1111/j.1538-7836.2007.02438.x
Ruutu, T; Barosi, G; Benjamin, RJ; Clark, RE; George, JN; Gratwohl, A; Holler, E; Iacobelli, M; Kentouche, K; Lämmle, B; Moake, JL; Richardson, P; Socié, G; Zeigler, Z; Niederwieser, D; Barbui, T; European, Group for Blood; Marrow, Transplantation; European, LeukemiaNet (2007). Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group. Haematologica - the hematology journal, 92(1), pp. 95-100. Pavia: Ferrata-Storti Foundation 10.3324/haematol.10699
Lämmle, B; Kremer Hovinga, J A (2006). A new tool to further explore the role of ADAMTS-13 in health and disease. Journal of thrombosis and haemostasis, 4(5), pp. 952-4. Oxford: Blackwell 10.1111/j.1538-7836.2006.01945.x
Fontana, S; Kremer Hovinga, J A; Lämmle, B; Mansouri Taleghani, B (2006). Treatment of thrombotic thrombocytopenic purpura. Vox sanguinis, 90(4), pp. 245-54. Oxford: Wiley-Blackwell 10.1111/j.1423-0410.2006.00747.x
Kremer Hovinga, J A; Mottini, M; Lämmle, B (2006). Measurement of ADAMTS-13 activity in plasma by the FRETS-VWF73 assay: comparison with other assay methods. Journal of thrombosis and haemostasis, 4(5), pp. 1146-8. Oxford: Blackwell 10.1111/j.1538-7836.2006.01904.x
Schnog, JJ; Hovinga, JA; Krieg, S; Akin, S; Lämmle, B; Brandjes, DP; Mac Gillavry, MR; Muskiet, FD; Duits, AJ; CURAMA, Study Group (2006). ADAMTS13 activity in sickle cell disease. American journal of hematology, 81(7), pp. 492-8. New York, N.Y.: Wiley-Liss 10.1002/ajh.20653
Terrell, D. R.; Williams, L. A.; Vesely, S. K.; Lämmle, B; Hovinga, J. A. K.; George, J. N. (2005). The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency. Journal of thrombosis and haemostasis, 3(7), pp. 1432-1436. Blackwell 10.1111/j.1538-7836.2005.01436.x
